A New Era Comes When Diabetes Can be Basically Treated Using Cells of Pancreas
– STC Life succeeded in differentiating pluripotent stem cells without side effect into beta-cells of pancreas, for the first time in the world
(SEOUL, SOUTH KOREA) STC Stem Cell Treatment & Research Institute(www.stcstri.com) of STC Life Co., Ltd. (Chairman: Kye Ho Lee) succeeded, after conducting research projects for several years, in differentiating new pluripotent stem cells without side effect into beta-cells that control insulin in pancreas. These new pluripotent stem cells can be differentiated into any tissues or organs without adverse effects.
Scientists at STC Stem Cell Treatment & Research Institute first created new pluripotent stem cells with no adverse effects and induced them to differentiate into beta-cells, and they identified their change into beta-cells 7 days thereafter. Then they identified generation of intact beta-cells by tracing insulin genes that typically appear in beta-cells.
Along with success in differentiation of beta-cells, they also succeeded in differentiating into multiple cells in a short span of time. The research team led by Dr. Lee Sang-Yeon said that they generated beta-cells in these processes for the first time in the world.
The research outcome is expected to be immediately applied to treating diabetes as it shows no adverse effects with outstanding safety.
“With development of technology that can successfully differentiate STC pluripotent stem cells without side effect into beta-cells of pancreas, physicians now can treat basic cause of diseases rather than simply mitigating symptoms,” said Kye Ho Lee, Chairman of STC Life. “As we developed natural substances-based pluripotent stem cells (We refer to as STC EPN : Elicited pluripotent stem cell from natural compound) and technology of differentiating diverse cells using such stem cells, after successfully differentiating beta-cells for nerves, cartilages, liver, bone, fat and pancreas, we will be able to lead the world stem cell market. We will grow as the world top life science company by developing cell therapies with world leading technologies.”
Established in 1989, STC Life is a life science company that concentrates resources on R&D of stem cells, genes related to controlling active oxygen in body (p62), life sciences, and energy water-based agriculture.
STC Life developed Pluripotent stem cell without side effects, the first of its kind in the world, and it obtained a total of 58 patents in Korea and other countries, including 17 patents related with STC Pluripotent stem cells. It is also a therapy-oriented life science company that is treating incurable diseases and down-aging using mesenchymal stem cells at 97.7 B&H Clinic.
With the mission of realizing vision and dream of bringing disease-free healthy life to people and extending lifespan while building a world with no poverty, STC Life will continuously develop new technologies to shape a better future.
STC Life Co., Ltd.
Director, Minsun Oh
+82 2 3438 0653
膵細胞利用により根本的治療の道が開かれる糖尿病 … STC Life、世界で初めて万能幹細胞から膵細胞への分化に成功
Ein neues Zeitalter der Diabetesbehandlung durch Einsatz von Bauchspeicheldrsenzellen hat begonnen
Inauguration d’une nouvelle re : traitement du diabte principalement l’aide des cellules pancratiques
Una Nueva Era Comienza Cuando se Puede Tratar la Diabetes, Bsicamente, con Clulas del Pncreas
Uma nova era surge na qual o diabetes pode ser tratado basicamente com o uso de clulas do pncreas
Si apre di fatto una nuova era in cui il diabete potr essere trattato di fatto usando le cellule del pancreas
Onderzoekers veranderen pluripotente stamcellen in betacellen (Dutch)